Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Gallmeier

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Developments in Biological Standardization|April 13, 1977
Randomized trial in advanced breast cancer using combination chemotherapy with or without C. parvum; preliminary resultsA C Mayr, H J Senn, W M Gallmeier, et al.
Deutsche Medizinische Wochenschrift (1946)|December 6, 1985
[Primary chemotherapy of advanced squamous epithelial carcinomas of the head and neck]U Bruntsch, T Hiller, H Wandt, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1975
[New Chemotherapeutic possibilities in the management of metastasizing testicular teratomas]S Seeber, W M Gallmeier, K Höffken, et al.
European Cytokine Network|July 1, 1993
Granulocyte-macrophage colony-stimulating factor (GM-CSF) reduces the density of stem cell factor receptors (c-kit oncogene product) on a GM-CSF-dependent human myeloid cell lineS Oez, G Hofmann-Wackersreuther, J Birkmann, et al.
Haematology and Blood Transfusion|January 1, 1977
Characterization of a human Hodgkin cell line and a lymphoblastic EBNA-negative cell line derived from a non-Hodgkin lymphoma patientW M Gallmeier, W R Boecker, U Bruntsch, et al.
Deutsche Medizinische Wochenschrift (1946)|June 13, 1975
[New chemotherapy (adriamycin, belomycin and vincristin) of metastasizing malignant testicular teratoma (author's transl)]S Seeber, W M Gallmeier, K Höffken, et al.
Journal of Hematotherapy & Stem Cell Research|January 14, 2000
The use of CD34+-selected PBPC after high-dose chemotherapy in breast cancer patients is associated with prolonged recovery time and increased infectious complicationsM Goerner, H Wandt, K Schäfer-Eckart, et al.
AIDS (London, England)|June 1, 1992
Low-dose oral natural human interferon-alpha in 29 patients with HIV-1 infection: a double-blind, randomized, placebo-controlled trialG Kaiser, H Jaeger, J Birkmann, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|April 1, 1977
[Chemotherapy of malignant bone tumors]K Höffken, S Seeber, W M Gallmeier, et al.
Investigational New Drugs|January 1, 1985
Phase-I study of mafosfamide-cyclohexylamine (ASTA-Z-7557, NSC 345 842) and limited phase-I data on mafosfamide-lysineU Bruntsch, G Groos, T A Hiller, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Developments in Biological Standardization|April 13, 1977
Randomized trial in advanced breast cancer using combination chemotherapy with or without C. parvum; preliminary resultsA C Mayr, H J Senn, W M Gallmeier, et al.
Deutsche Medizinische Wochenschrift (1946)|December 6, 1985
[Primary chemotherapy of advanced squamous epithelial carcinomas of the head and neck]U Bruntsch, T Hiller, H Wandt, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1975
[New Chemotherapeutic possibilities in the management of metastasizing testicular teratomas]S Seeber, W M Gallmeier, K Höffken, et al.
European Cytokine Network|July 1, 1993
Granulocyte-macrophage colony-stimulating factor (GM-CSF) reduces the density of stem cell factor receptors (c-kit oncogene product) on a GM-CSF-dependent human myeloid cell lineS Oez, G Hofmann-Wackersreuther, J Birkmann, et al.
Haematology and Blood Transfusion|January 1, 1977
Characterization of a human Hodgkin cell line and a lymphoblastic EBNA-negative cell line derived from a non-Hodgkin lymphoma patientW M Gallmeier, W R Boecker, U Bruntsch, et al.
Deutsche Medizinische Wochenschrift (1946)|June 13, 1975
[New chemotherapy (adriamycin, belomycin and vincristin) of metastasizing malignant testicular teratoma (author's transl)]S Seeber, W M Gallmeier, K Höffken, et al.
Journal of Hematotherapy & Stem Cell Research|January 14, 2000
The use of CD34+-selected PBPC after high-dose chemotherapy in breast cancer patients is associated with prolonged recovery time and increased infectious complicationsM Goerner, H Wandt, K Schäfer-Eckart, et al.
AIDS (London, England)|June 1, 1992
Low-dose oral natural human interferon-alpha in 29 patients with HIV-1 infection: a double-blind, randomized, placebo-controlled trialG Kaiser, H Jaeger, J Birkmann, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|April 1, 1977
[Chemotherapy of malignant bone tumors]K Höffken, S Seeber, W M Gallmeier, et al.
Investigational New Drugs|January 1, 1985
Phase-I study of mafosfamide-cyclohexylamine (ASTA-Z-7557, NSC 345 842) and limited phase-I data on mafosfamide-lysineU Bruntsch, G Groos, T A Hiller, et al.
Pageof 9